<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03438084</url>
  </required_header>
  <id_info>
    <org_study_id>HR-</org_study_id>
    <nct_id>NCT03438084</nct_id>
  </id_info>
  <brief_title>The INTER-CARDIO Study: The Impact of Commonly Consumed Fat on Cardiovascular Health; a Randomised Controlled Trial</brief_title>
  <acronym>INTER-CARDIO</acronym>
  <official_title>The INTER-CARDIO Study: The Impact of Commonly Consumed Fat on Cardiovascular</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King's College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>King's College London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate whether there are differences in postprandial
      cardiometabolic metabolic indices following interesterified fats used commercially versus
      application appropriate non- interesterifed alternative fat.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim: The current study aims to investigate the acute effects of commercially available
      interesterified fat versus versus application appropriate non- interesterifed alternative fat
      on 8 h postprandial cardiometabolic outcomes.

      Hypothesis: Interesterified fat will induce a different cardiomtabolic response compared to a
      non interesterifed, application appropriate fat.

      Subjects: Participants will include 40 healthy male and female volunteers aged between the
      ages of 35 and 75 years (since during this age metabolic changes start to take place).

      Power calculation: Based on previous studies carried out by our group at King's College
      London, a sample size of 20 participants (males and females separately) will allow a 2.16%
      (percentage unit) difference in FMD to be detected (90% power, 0.05 alpha, SD 2.9. 50
      participants will be recruited allowing for a 20% dropout rate.

      Expected value:The study will provide novel information on the acute effects of commercially
      relevant processed fats on postprandial lipaemia.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial function</measure>
    <time_frame>Up to 8 hours</time_frame>
    <description>Flow mediated dilatation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postprandial lipaemic response</measure>
    <time_frame>Up to 8 hours</time_frame>
    <description>Area under plasma TAG concentration/ time curve</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postprandial lipaemic response</measure>
    <time_frame>Up to 8 hours</time_frame>
    <description>Postprandial plamsa total fatty acid composition and non esterifed fatty acid</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolomic for assessment of atherogenic potential (lipoprotein) analysis</measure>
    <time_frame>Up to 8 hours</time_frame>
    <description>Lipid concentrations and compositions of 14 lipoprotein subclasses, measured by NMR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycaemic response</measure>
    <time_frame>Up to 8 hours</time_frame>
    <description>Plasma glucose concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulinaemic response</measure>
    <time_frame>Up to 8 hours</time_frame>
    <description>Plasma insulin concnetration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nitric oxide bioavailability</measure>
    <time_frame>Up to 8 hours</time_frame>
    <description>Plasma nitric oxide species and NADPH oxidase activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidative stress</measure>
    <time_frame>Up to 8 hours</time_frame>
    <description>Plasma 8-isoprostane F2a</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory response</measure>
    <time_frame>Up to 8 hours</time_frame>
    <description>Plasma IL-6</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Healthy Adults</condition>
  <arm_group>
    <arm_group_label>Interesterified</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Commercially available interesterifed fat spread. 50g fat.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non- interesterified</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Commercially available non-interesterified fat. 50g fat.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Rapeseed oil. 50 g fat.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Interesterified fat</intervention_name>
    <description>50 g fat provided as commercially available interesterified fat.</description>
    <arm_group_label>Interesterified</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Non- interesterified fat</intervention_name>
    <description>50 g fat provided as commercially available non-interesterified fat.</description>
    <arm_group_label>Non- interesterified</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Rapeseed oil</intervention_name>
    <description>50 g fat provided as commercially available rapeseed oil.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females aged 35-75 years

          -  Healthy (free of diagnosed diseases listed in exclusion criteria)

          -  Able to understand the information sheet and willing to comply with study protocol

          -  Able to give informed consent

        Exclusion Criteria:

          -  Medical history of myocardial infarction, angina, thrombosis, stroke, cancer, liver or
             bowel disease or diabetes

          -  Body mass index &lt; 20 kg/m2 or &gt; 35 kg/m2

          -  Plasma cholesterol ≥7.5 mmol/L

          -  Plasma triacylglycerol &gt; 3 mmol/L

          -  Plasma glucose &gt; 7 mmol/L

          -  Blood pressure ≥140/90 mmHg

          -  Current use of antihypertensive or lipid lowering medications

          -  Premenopausal (for women)

          -  Alcohol intake exceeding a moderate intake (&gt; 28 units per week)

          -  Current cigarette smoker (or quit withint the last 6 months)

          -  ≥ 20% 10-year risk of CVD as calculated using a risk calculator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sarah EE Berry, PhD</last_name>
    <phone>+44 0207 848 4088</phone>
    <phone_ext>4088</phone_ext>
    <email>sarah.e.berry@kcl.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Charlotte E Mills, PhD</last_name>
    <phone>+ 44 0207 848 4345</phone>
    <phone_ext>4345</phone_ext>
    <email>charlotte.1.mils@kcl.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Nutritional Sciences, Faculty of Life Sciences and Medicine, Kings College London</name>
      <address>
        <city>London</city>
        <zip>SE1 9NH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King's College London</name>
      <address>
        <city>London</city>
        <zip>SE1 9NH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2018</study_first_submitted>
  <study_first_submitted_qc>February 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 19, 2018</study_first_posted>
  <last_update_submitted>April 26, 2018</last_update_submitted>
  <last_update_submitted_qc>April 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Interesterified</keyword>
  <keyword>Postprandial</keyword>
  <keyword>Lipid</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

